about
Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesNon-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatmentNonmedicinal interventions in nonalcoholic fatty liver diseaseNonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionineThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?Non-alcoholic fatty liver disease: need for a balanced nutritional sourceNon-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin StudyIndications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisImaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseNonalcoholic Steatohepatitis and Endpoints in Clinical Trials.Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Acoustic Radiation Force Impulse Elastography for the Non-Invasive Evaluation of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review & Meta-Analysis.Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Domain Analysis of Integrated Data to Reduce Cost Associated with Liver Disease.Transient elastography as a screening tool for liver fibrosis in a large hemodialysis populationAdvances in the diagnosis and treatment of nonalcoholic steatohepatitis.Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram.A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver diseaseThe clinical significance of serum ferritin in pediatric non-alcoholic Fatty liver diseaseUsefulness of the controlled attenuation parameter for detecting liver steatosis in health checkup examineesPractical approach to non-alcoholic fatty liver disease in patients with diabetes.Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD.Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic FeaturesVitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng StudyPanel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH.A Comparison of Brunt's Criteria, the Non-Alcoholic Fatty Liver Disease Activity Score (NAS), and a Proposed NAS Scoring that Includes Fibrosis in Non-Alcoholic Fatty Liver Disease StagingSteatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.Fractionation of gamma-glutamyltransferase in patients with nonalcoholic fatty liver disease and alcoholic liver disease.Liver Illness and Psychiatric Patients.
P2860
Q26767276-ED065AFF-0AF1-48FD-BCFE-AEEDDEB5BDC4Q26780252-220CF05F-723B-4442-8BAB-78259CCFE01AQ26828855-EC284E5E-8B3D-489A-BAE4-C42BF2435892Q26852019-59729B7D-0A88-46C8-B319-028DBE480EF7Q26992054-AFFAAA56-22FB-470C-BBA2-55366D40B037Q26992163-B2CE1FDD-871A-42F5-9CA6-A44F54A151A3Q27008277-F4B96F7B-35E0-4CB0-9D5F-F81708F8227EQ28079445-6AEB411B-DD05-4632-A87B-DA19AD41FE8FQ28084035-B5C92E1F-A6A5-4B41-A3FB-013C2310E009Q28248994-511804C5-EFC2-4377-AE9B-32F70073F965Q30235846-261F9682-64F5-4E69-A61B-E275393293B4Q30366569-E1B381C6-2A94-47D3-A7E4-1D31E58C6028Q30366572-497999AF-13FE-46B8-AA91-9258B2918614Q30368624-0E87F67C-4004-428B-8907-F21845F4865DQ30368738-1E42B0CB-EABD-4AF1-80C7-F679BEA4396AQ30376231-A2F35B0C-E367-41A0-9FBA-10483E1EE558Q30396916-D51FF402-78B9-439F-BE5F-4310BD3AD67FQ30397191-164FCB17-C215-4245-9A64-6143031336DAQ30406900-EE74125C-BFEC-4F89-944C-F7805967CBCBQ30418856-42466FD7-213E-4D3C-BAAC-894A0929E517Q30986369-C27622C3-B084-404E-9663-9FF2F36A96EDQ33577504-185E5245-C010-489B-967E-292CAF9B59F4Q33582176-F6E059A2-BB63-4BDB-8FC8-B240E3AC29BDQ33591227-59BCBE4D-0044-4748-A095-6FE41C0495C3Q34070770-A9573308-674A-4C64-9A0A-FB519AD1F1D1Q34923599-EDF958E3-73A7-4148-9C63-685BD2656586Q35551319-3219C38B-5F76-4EF1-939D-F2AED20FBB7CQ35561693-CA1E6EAF-1286-41E6-8A39-A3BB19469543Q35769495-8ECEAD8A-ED4D-4AFC-8392-B18F18F460D9Q35850234-3AA00010-4310-46E1-B3B0-14FADF378B19Q36047914-ACAE9F7C-1160-4102-8A61-0FD5892005D2Q36310780-B45B2EFC-CB01-4C8B-ACB8-595038AE0DE2Q36324068-B6A8DC6E-DE00-4913-B7C3-2CDF000D5639Q36329460-DF936F78-6E26-4227-9E4C-0EEA53C468A8Q36485353-1FE27E18-8BE5-451A-8936-4085A6D4E676Q37088653-A8B17324-73AA-427C-BCC6-D92CA04C97E8Q37384502-6F717D6D-523E-4591-AC21-1301693F3BA5Q37392542-D6230EF0-26EF-4771-A51A-20378919C18EQ37539654-4D67705F-6944-4C2C-ABA5-3BCF82728106Q37587062-F39F4CB8-AB4E-4382-8B5E-7460108AEC66
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Noninvasive evaluation of NAFLD.
@en
type
label
Noninvasive evaluation of NAFLD.
@en
prefLabel
Noninvasive evaluation of NAFLD.
@en
P2860
P1476
Noninvasive evaluation of NAFLD
@en
P2093
Paul Angulo
Valérie Vilgrain
P2860
P2888
P304
P356
10.1038/NRGASTRO.2013.175
P407
P577
2013-09-24T00:00:00Z